By G HossainPosted on August 1, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs In its first commercial quarter for ATTR-cardiomyopathy, Alnylam’s Amvuttra reached roughly 1,400 patients and made more than $490 million. ‘Very Impressive’ Amvuttra ATTR-CM Sales Send Alnylam Soaring Post navigation Merck’s $3B Savings Push Claims 6,000 JobsModerna’s Bancel Nay on M&A, Yay on R&D Partnerships